Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: The doxycycline trial

Rheumatic Disease Clinics of North America

Volumn 32, Issue 1, 2006, Pages 217-234

  Brandt, Kenneth D ^a   Mazzuca, Steven A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHONDROITIN SULFATE; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXYCYCLINE; GLUCOSAMINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; TETRACYCLINE DERIVATIVE;

CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; FUNCTION TEST; GASTROINTESTINAL SYMPTOM; HUMAN; JOINT CAVITY; KNEE OSTEOARTHRITIS; KNEE PAIN; KNEE RADIOGRAPHY; NONHUMAN; PAIN ASSESSMENT; PHOTOSENSITIVITY; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; VAGINA CANDIDIASIS; VAGINITIS;

ANTI-BACTERIAL AGENTS; COLLAGENASES; DOXYCYCLINE; FEMALE; HUMANS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33344461637     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.11.002     Document Type: Review

References (55)

1. K.D. Brandt Non-surgical treatment of osteoarthritis: a half century of "advances" Ann Rheum Dis 63 2004 117 122
2. P. De Pablo, and M.H. Liang Finding clinical endpoints and biosurrogates in preclinical knee osteoarthritis J Rheumatol 32 2005 1152 1154
3. K.D. Brandt, S.A. Mazzuca, and T. Conrozier Which is the best radiologic/radiographic protocol for a clinical trial of a structure-modifying drug in patients with knee osteoarthritis? Proceedings of January 17-18, 2002 Workshop in Toussus-le-Noble, France J Rheumatol 29 2002 1308 1320
4. K.D. Brandt, S.A. Mazzuca, and B.P. Katz Effect of doxycycline on progression of osteoarthritis Arthritis Rheum 52 2005 2015 2025
5. L.P. Yu, G.N. Smith, and K.A. Hasty Doxycycline inhibits type XI collagenolytic activity of extracts from human osteoarthritic cartilage and of gelatinase J Rheumatol 18 1991 1450 1452
6. G.N. Smith Jr, K.D. Brandt, and K.A. Hasty Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity Arthritis Rheum 39 1996 235 244
7. A.R. Amin, M.G. Attur, and G.D. Thakker A novel mechanism of action of tetracyclines: effects on nitric oxide synthases Proc Natl Acad Sci U SA 93 1996 14014 14019
8. M. Lotz The role of nitric oxide in articular cartilage damage Rheum Dis Clin North Am 25 1999 269 282
9. L.M. Golub, H.M. Lee, and G. Lehrer Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action J Periodontal Res 18 1983 516 526
10. L.P. Yu Jr, G.N. Smith, and K.D. Brandt Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline Arthritis Rheum 35 1992 1150 1159
11. G. Smith Jr, L. Yu Jr, and K. Brandt Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage J Rheumatol 25 1998 532 535
12. R.A. Greenwald Treatment of destructive arthritis disorders with MMP inhibitors Ann N Y Acad Sci 731 1994 181 198
13. Golub L.M., Ramamurthy N.S., McNamara T.F. et al, inventors; Kurary Co, Ltd, assignee. Method to reduce connective tissue destruction. US patent 5 258 371. November 3, 1993
14. T.D. Spector, D.J. Hart, and D.V. Doyle Incidence and progression of osteoarthritis in women with unilateral knee disease in the general population: the effect of obesity Ann Rheum Dis 53 1994 565 568
15. R.B. Haynes, and R. Dantes Patient compliance and the conduct and interpretation of therapeutic trials Control Clin Trials 8 1987 12 39
16. J.M. Lang The use of a run-in to enhance compliance Stat Med 9 1990 87 95
17. G.L. Archer, and R.E. Polk Treatment and prophylaxis of bacterial infections A.S. Fauci E. Braunwald K.J. Isselbacher Harrison's principals of internal medicine 14th edition 1998 McGraw-Hill New York 856 869
18. A.A. Cole, S. Chubinskaya, and L.J. Luchene Doxycycline disrupts chondrocyte differentiation and inhibits cartilage matrix degradation Arthritis Rheum 37 1994 1727 1734
19. J.C. Buckland-Wright, D.G. Macfarlane, and S.A. Williams Accuracy and precision of joint space width measurements in standard and macroradiographs of osteoarthritic knees Ann Rheum Dis 54 1995 872 880
20. W.G. Carson Jr, S.L. James, and R.L. Larson Patellofemoral disorders: physical and radiographic evaluation. Part II: Radiographic examination Clin Orthop Relat Res 185 1984 178 186
21. M. Lequesne Quantitative measurements of joint space during progression of osteoarthritis: chondrometry K. Kuettner V. Goldberg Osteoarthritic disorders 1995 American Academy of Orthopedic Surgeons Rosemont (IL) 427 444
22. S.A. Mazzuca, K.D. Brandt, and K.A. Buckwalter Pitfalls in the accurate measurement of joint space narrowing in semiflexed anteroposterior radiographs of the knee Arthritis Rheum 50 2004 2508 2515
23. N. Bellamy, W.W. Buchanan, and C.H. Goldsmith Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee J Rheumatol 15 1988 1833 1840
24. V. Strand, and A. Kelman Outcome measures in osteoarthritis: randomized controlled trials Curr Rheum Rep 6 2004 20 30
25. F. Tubach, P. Ravaud, and G. Baron Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimally clinically important improvement Ann Rheum Dis 64 2005 29 33
26. K.D. Brandt Disease-modifying osteoarthritis drugs (DMOADs). The clinical perspective K.D. Brandt M. Doherty S.L. Lohmander Osteoarthritis 2nd edition 2003 Oxford University Press Oxford (England) 401 409
27. S.A. Mazzuca, K.D. Brandt, and C. German Development of radiographic changes of osteoarthritis in the "Chingford knee" reflects progression of disease or non-standardized positioning of the joint, rather than incident disease Ann Rheum Dis 62 2003 1061 1065
28. J.Y. Reginster, R. Deroisy, and L.C. Rovati Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial Lancet 357 2001 251 256
29. K. Pavelka, J. Gatterova, and M. Olejarova Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study Arch Intern Med 162 2002 2113 2123
30. B.A. Michel, G. Stucki, and D. Frey Chondroitin 4 & 6 sulphate in knee osteoarthritis Arthritis Rheum 52 2005 779 786
31. D. Uebelhart, M. Malaise, and R. Marcolongo Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo Osteoarthritis Cartilage 12 2004 269 276
32. M. Dougados, M. Nguyen, and L. Berdah Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the chondromodulating effect of diacerein in OA of the hip Arthritis Rheum 44 2001 2539 2547
33. T. Pham, A. Le Henanff, and P. Ravaud Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NDR101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis Ann Rheum Dis 63 2004 1611 1617
34. R.W. Jubb, S. Piva, and L. Beinat A one-year, randomised placebo (saline) controlled trial of 500-730 kDa sodium hyaluronate (Hyalgan®) on the radiologic change in osteoarthritis of the knee Int J Clin Pract 57 2003 467 474
35. T.D. Spector, P. Conaghan, and J.C. Buckland-Wright Risedronate produces disease modification and symptomatic benefit in treatment of knee osteoarthritis: results from the BRISK study Arthritis Rheum 48 12 2003 3650
36. G.R. Squires, S. Okouneff, and M. Ionescu The pathobiology of focal lesion development in aging human articular cartilage and molecule matrix changes characteristic of osteoarthritis Arthritis Rheum 48 2003 1261 1270
37. T. Aigner, A. Zien, and D. Hanisch Gene expression in chondrocytes assessed with use of microarrays J Bone Joint Surg Am 85-A Suppl 2 2003 117 123
38. S.A. Mazzuca, K.D. Brandt, and B.P. Katz Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug Arthritis Care Res 51 2004 933 940
39. V.G. Wilhelmi Fordernde und hemmende Einflusse von Tribenosid und Acetylsalicylsaure auf die spontane Arthrose der Maus Arzneimittelforschung 28 1978 1724 1726
40. M.J. Palmoski, and K.D. Brandt In vivo effect of aspirin on canine osteoarthritic cartilage Arthritis Rheum 26 1983 994 999
41. J.P. Raynauld, C. Buckland-Wright, and R. Ward Safety and efficacy of longterm intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial Arthritis Rheum 48 2003 370 377
42. V. Listrat, X. Ayral, and F. Patarnello Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee Osteoarthritis Cartilage 5 1997 153 160
43. T.E. McAlindon, P. Jacques, and Y. Zhang Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 39 1996 648 656
44. T.E. McAlindon, D.T. Felson, and Y. Zhang Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study Ann Intern Med 125 1996 353 359
45. T. Pham, D. Van Der Heijde, M. Lassere OMERACT-OARSI Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria J Rheumatol 30 7 2003 1648 1654
46. S.L. Myers, K.D. Brandt, and J.W. Ehlich Synovial inflammation in patients with early osteoarthritis of the knee J Rheumatol 17 1990 1662 1669
47. X. Ayral, M. Dougados, and V. Listrat Arthroscopic evaluation of chondropathy in osteoarthritis of the knee J Rheumatol 26 1996 1140 1147
48. C. Peterfy, J. Li, and S. Ziam Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility Skeletal Radiol 32 2003 128 132
49. J.C. Buckland-Wright, F. Wolfe, and R.J. Ward Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed AP, and schuss views J Rheumatol 26 1999 2664 2674
50. E. Vignon, M. Piperno, and M.P. Le Graverand Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee. Comparison of standing anteroposterior and Lyon schuss views Arthritis Rheum 48 2003 378 384
51. S.A. Mazzuca, K.B. Brandt, and K.A. Buckwalter Detection of radiographic joint space narrowing in subjects with knee osteoarthritis: longitudinal comparison of the metatarsophalangeal and semiflexed anteroposterior view Arthritis Rheum 48 2003 385 390
52. J.G. Adams, T. McAlindon, and M. Dimasi Contribution of meniscal extrusion and cartilage loss to joint space narrowing in osteoarthritis Clin Radiol 54 1999 502 506
53. D.J. Hunter, X. Tu, and M. LaValley The meniscus and cartilage loss [abstract] Arthritis Rheum 50 Suppl 9 2004 S141
54. S.S. Messieh, P.J. Fowler, and T. Munro Anteroposterior radiographs of the osteoarthritic knee J Bone Joint Surg Br 72 1990 639 640
55. S.A. Mazzuca, K.D. Brandt, and K.A. Buckwalter Knee pain reduces joint space width in conventional standing anteroposterior radiographs of osteoarthritic knees Arthritis Rheum 46 2002 1223 1227